| Active substance |
Duloxetine |
| Also known as |
Cymbalta |
| Blood pressure |
No direct effect |
| Chemical name |
Adalimumab |
| Dosage (medical) |
Typically 40 mg every other week |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces inflammation and disease activity |
| Formula |
C6428H9912N1694O1987S46 |
| Half-life |
Approximately 14-19 days |
| Hepatotoxicity |
Low risk |
| Lab Test |
Monitoring of liver enzymes and blood counts may be required |
| Main action |
TNF inhibitor |
| Side effects |
Injection site reactions, risk of infections, headaches, rash |
| Storage conditions |
Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Strength |
20 mg |
| Substance class |
Monoclonal antibody |
| Trade name |
Humira |
| Use in sports |
None |
| Water Retention |
Minimal |
| Manufacturer |
Sun Pharma Laboratories Ltd. |
| Packing |
10 caps/blister |
